Ontology highlight
ABSTRACT:
SUBMITTER: Xu L
PROVIDER: S-EPMC7797660 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Xu Linyan L Gao Xiang X Yang Pu P Sang Wei W Jiao Jun J Niu Mingshan M Liu Mengdi M Qin Yuanyuan Y Yan Dongmei D Song Xuguang X Sun Cai C Tian Yu Y Zhu Feng F Sun Xiaoshen X Zeng Lingyu L Li Zhenyu Z Xu Kailin K
Journal of Cancer 20210101 4
Despite advancement in the treatment of diffuse large B-cell lymphoma (DLBCL), many patients tend to relapse or become refractory after initial therapy. Therefore, it is essential to identify novel therapeutic targets and drugs, understand the molecular pathogenesis mechanism of DLBCL, and find ways to prevent and treat relapsed or refractory DLBCL. BIX-01294 is a small molecule compound that specifically inhibits EHMT2 activity. In this study, we demonstrate that BIX-01294 triggered the inhibit ...[more]